UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

Two later-stage trials investigating LSD for treating anxiety are due to conclude in 2026, which could lead to the drug being ...

San Francisco’s UCSF is stepping into the national spotlight as one of several university medical centers testing whether a ...

LSD is a drug often associated with the counter-culture of the 1960s. But it is being studied as a promising therapy for ...

MindBio Therapeutics Corp. MBIO WF have started pre-screening for participant entry into phase 2 LSD-microdosing clinical trials. The clinical trials are a for take home use of MindBio's ...

Scientists from the pharmaceutical company, MindMed, have announced the beginning of Phase 1 clinical trials to test Schedule 1 drugs MDMA and LSD. The trial will commence in Basel, Switzerland, later ...

A New York-based biotech firm has begun a clinical trial to study LSD as a treatment for anxiety, announcing last week that it had administered the psychedelic drug to a patient enrolled in the study ...

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...

MindBio Therapeutics Corp. said that “MB22001, a proprietary and self-titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing” has been approved for take-home use ...

The world’s first Phase One clinical trial investigating the microdosing of LSD showed promise. During our recent adventure to Microdose’s Wonderland festivities in Miami, we were hit with a mountain ...